scholarly article | Q13442814 |
P356 | DOI | 10.1159/000227815 |
P698 | PubMed publication ID | 19590195 |
P50 | author | Heribert Schunkert | Q28039319 |
Tobias Hannes | Q38804565 | ||
Marius Wernig | Q74884461 | ||
Rudolf Jaenisch | Q90073 | ||
P2093 | author name string | Huamin Liang | |
Kurt Pfannkuche | |||
Marcel Halbach | |||
Juergen Hescheler | |||
Filomain Nguemo | |||
Matthias Matzkies | |||
Michael Reppel | |||
Frank Pillekamp | |||
Jiaoya Xi | |||
Azra Fatima | |||
Tomo Sarić | |||
P433 | issue | 1-2 | |
P304 | page(s) | 73-86 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Cellular Physiology and Biochemistry | Q2229420 |
P1476 | title | Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. | |
P478 | volume | 24 |
Q27347592 | Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients |
Q36307694 | Cardiac biomarkers: a focus on cardiac regeneration. |
Q37800141 | Cardiac cell therapies: the next generation |
Q37959029 | Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models |
Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
Q39314351 | Chondrogenic differentiation in vitro of murine two-factor induced pluripotent stem cells is comparable to murine embryonic stem cells |
Q38120521 | Connexin expression and gap-junctional intercellular communication in ES cells and iPS cells |
Q35958875 | Defining the nature of human pluripotent stem cell progeny |
Q64060131 | Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells |
Q44697186 | Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain |
Q27024431 | Functional cardiac tissue engineering |
Q54373340 | Functional characterization and gene expression profiling of α-smooth muscle actin expressing cardiomyocytes derived from murine induced pluripotent stem cells. |
Q33693259 | Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar |
Q37999164 | Guiding differentiation of stem cells in vivo by tetracycline-controlled expression of key transcription factors. |
Q34430500 | Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability |
Q37801268 | Induced pluripotent stem cells: developmental biology to regenerative medicine |
Q30420062 | Inducible pluripotent stem cells: not quite ready for prime time? |
Q33539807 | Initial colony morphology-based selection for iPS cells derived from adult fibroblasts is substantially improved by temporary UTF1-based selection |
Q52607493 | Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy. |
Q42108199 | Isolation and Functional Characterization of Pluripotent Stem Cell–Derived Cardiac Progenitor Cells |
Q27024992 | Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes |
Q90683736 | Mending a broken heart: current strategies and limitations of cell-based therapy |
Q34619318 | Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells |
Q38063951 | Personalized cardiac regeneration by stem cells-Hype or hope? |
Q88219970 | Preclinical Studies of Stem Cell Therapy for Heart Disease |
Q37766194 | Stem cell therapy for chronic myocardial infarction |
Q39850212 | Stem cell therapy for ischemic heart disease |
Q38050281 | Stem cell-based therapy for ischemic heart disease. |
Q38843402 | Stem cells and diabetic cardiomyopathy: from pathology to therapy |
Q41137829 | Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation. |
Q35563251 | Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling |
Q42542823 | The Interaction between Adult Cardiac Fibroblasts and Embryonic Stem Cell-Derived Cardiomyocytes Leads to Proarrhythmic Changes in In Vitro Cocultures. |
Q27321569 | The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells. |
Q34186790 | Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells. |
Q36735280 | Tissue-Mimicking Geometrical Constraints Stimulate Tissue-Like Constitution and Activity of Mouse Neonatal and Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes |
Search more.